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COMPARING EFFECTIVENESS BETWEEN INTRAMUSCULAR AND 
INTRADERMAL TRIVALENT INFLUENZA VACCINATION IN NURSING 
HOME RESIDENTS: A RANDOMISED CONTROLLED TRIAL 
TC Chan, IFN Hung, JKH Luk, LW Chu, FHW Chan 
 
Department of Medicine, Queen Mary Hospital and Fung Yiu King Hospital, Hong Kong 
 
BACKGROUND: There is no study comparing clinical effectiveness between 
intradermal (ID) and intramuscular (IM) administration of influenza vaccination in 
nursing home older adults. 
 
METHODS: This was a single-centre, randomised, controlled, open-label, parallel group 
trial from October 2013 to April 2014 in nine nursing homes comparing the effectiveness 
between full-dose IM and ID immunisation of the trivalent influenza vaccine. Outcomes 
were 1-year hospitalisation due to pneumonia and 1-year laboratoryconfirmed influenza 
infection between the two groups. 
 
RESULTS: Overall, 100 nursing home older adults (mean age, 82.9 ± 7.4 years; male, 
36%) were randomised. Baseline characteristics were similar between the two groups. At 
1 year, 8 and 11 participants were hospitalized at least once due to pneumonia in ID and 
IM groups, respectively (P=0.44). Two and four participants had laboratory-confirmed 
influenza infection in ID and IM group, respectively (P=0.68). 
 
CONCLUSION: ID vaccination of influenza vaccine may not be more effective than IM 
vaccination. However, this study was limited by its small sample size and both clinical 
outcomes were lower in ID group. Clinical trial with larger sample size would be 
necessary. 
